Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus

Clinical Pediatrics

Volumn 37, Issue 2, 1998, Pages 73-80

  Stuart, Charles A ^a   Gilkison, Charles R ^b   Smith, Michele M ^b   Bosma, Anna M ^b   Keenan, Bruce S ^b   Nagamani, Manubai ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; CHILD; CONFERENCE PAPER; DISEASE ASSOCIATION; GLUCOSE INTOLERANCE; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; MATERNAL DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0031890938     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289803700203     Document Type: Conference Paper

References (23)

1. Acanthosis Nigricans. In: Rook A, Wilkinson DS, Ebling FJG, eds. Textbook of Dermatology. Oxford: Blackwell Scientific; 1979:1307-1310.
2. Kalin CR, Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
3. Taylor SI, Accili D, Came A, et al. Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance. Adv Exp Med Biol. 1991;293:197-213.
4. St Liart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269-272.
5. St Liart CA, Smith MM, Gilkison CR, et al. Acanthosis nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health. 1994;84:1839-1842.
6. Cruz PD Jr, HID JA Jr. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol. 1992;98(Suppl.):82S-85S.
7. Krane JF, Murphy DP, Carter DM. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-1) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol. 1991;96:419-425.
8. Liu J-P, Baker J, Perking AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (If-1) and type I IF receptor (Igflr). Cell 1993;75:59-72.
9. Mtirillas R, Larclier F, Coiiti CJ, et al. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 1995;14:5216-5223.
10. Taylor SI, Accili D, Imiai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 1994;43:735-740.
11. Stuart CA, Gilkison CR, Keen an BS, Nagamani M. Hyperinsulinemia and acanthosis nigricans in African Americans, J Natl Med Assoc.(in press).
12. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36:523-534.
13. Stuart CA, Nagamani M. Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril 1990;54:788-792.
14. St Liart CA, Prince MJ, Smith ER. et al. In vivo stimulation of androstenedione and dehydropiandrosterone secretion by insulin infusion in insulin resistant women. Infertility. 1992;15:85-100.
15. Foreknown E, Btizzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
16. Sepehrnia B, Prezant TR, Rotter JI, et al. Screening for mtDNA diabetes mutations in Pima Indians with NIDDM. Am J Med Genet. 1995;56:198-202.
17. Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin dependent diabetes mellitus. Diabetes Mttalt Rev. 1989;5:83-109.
18. Reaven GM. Role of insulin resistance In human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121-131.
19. Raven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. 1994;37:948-952.
20. Peters EJ, Stuart CA, Prince MJ. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism. 1986;35:807-813.
21. Harris MI, Hamden WC, Knower WC, Bennett PH. International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Can. 1985;8:562-567.
22. Harris MI. Epidemiological correlates of NIDDM in Hispanics, Whites, and Blacks in the U.S. Population. Diabetes Care. 1991;14:639-648.
23. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:l-27.